Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 EBIT

The latest EBIT for AIZN is $1.4B as of September 2026. That compares with $1.1B in the prior-year period — up 26.1% year over year. That is below the Finance sector average of $42T. Investors often review this figure alongside Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's historical trend and sector peers before judging valuation or financial health.

Over the past year, AIZN's EBIT moved from $1.1B to $1.4B — a 26.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's operating scale or balance-sheet position.

Against Finance companies, AIZN currently prints $1.4B for EBIT, while the sector average sits near $42T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's growth, margins, and balance sheet.

A EBIT figure of $1.4B for AIZN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $42T. Explore the charts below for those layers of context.

After noting AIZN's EBIT ($1.4B), review year-over-year change from $1.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.